Business Opportunities

Fortis receives Sebi nod Rs 997 cr rights issue

Hospital chain Fortis Healthcare today said it has got approval from the regulatory body Sebi for its Rs 997-crore rights issue for funding some of its expansion projects and its recent acquisition of Workhardt Hospitals. - 'Over 3,000 people will be a part of Fortis' - Fortis plans Rs 1,000-cr rights issue by October - Fortis Healthcare"s Rs 1,000-cr rights issue likely by Oct - Hospital sale to help Khorakiwala repay Rs 500 cr debt - Fortis Healthcare: Booster dose - Fortis to buy 10 Wockhardt hospitals in Rs 909-cr deal Sebi has given approval for issue of equity shares with warrants on a rights basis at a price of Rs 110 per equity share amounting to Rs 997 crore, which exclude the value of warrants, Fortis Healthcare said in a statement. The rights issue is likely to open by the end of this month. As part of the process, shareholders of Fortis shall be entitled to subscribe to two right shares for every five equity shares held as on the record date. The company will use the money for funding some of its greenfield projects, besides redemption of preference shares, repayment of short term debt, upgrade of existing facilities and part funding for acquisition of 10 hospitals from Wockhardt Hospitals, the statement added. Fortis had acquired 10 hospitals from Wockhardt in August for Rs 909 crore.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Petro board to identify 300 cities for gas networks
The board plans to reduce the period for laying city gas pipelines.
Popular Articles

Sunil Sethi: The crisis of identity proofs
- Sunil Sethi: Remembering Oct 31, 1984">Sunil Sethi: Remembering Oct 31, 1984 - Sunil Sethi: The price of a filmmaker's estate">Sunil Sethi: The price of a filmmaker's estate - Sunil Sethi: Marketing the gifts of gods">Sunil Sethi: Marketing the gifts of gods - Sunil Sethi: The difficulty of being Khan">Sunil Sethi: The difficulty of being Khan - Sunil Sethi: Delhi's double displacement">Sunil Sethi: Delhi's double displacement - Sunil Sethi: Virtue, vice and VIPs">Sunil Sethi: Virtue, vice and VIPs

Aurobindo gets nod to market 2 more products in S Africa
Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received approval from the Medicines Control Council (MMC) to manufacture and market two more products in South Africa.